Whistleblower News & Articles

Home > Whistleblower News & Articles > Whistleblower Law Collaborative’s Bob Thomas Speaks at the 27th Annual Pharma Congress

Related Content

Whistleblower Law Collaborative Proud to Speak at and Sponsor the Anti-Fraud Coalition 26th Annual Conference

At Whistleblower Law Collaborative, our commitment to fighting fraud and supporting whistleblowers is at the heart of what we do....

Augustine Ripa and Erica Blachman Hitchings Quoted in Law360 Article Addressing Updated Justice Manual

A version of this article, authored by Dan McKay, appeared in Law360’s Healthcare Authority on September 29, 2026.  WLC partners Augustine...

Bruce Judge to Speak on Cybersecurity Fraud Enforcement at ABA Joint Committee Meeting

Coming up on June 11, Bruce Judge will join a panel of experts at a joint meeting of the American...

WLC Partners to Speak at ABA Qui Tam & Civil False Claims and Healthcare Fraud Institute

We are pleased to announce that WLC partners Bruce Judge and Erica Hitchings will serve as faculty at the highly...

Whistleblower Law Collaborative’s Bob Thomas Speaks at the 27th Annual Pharma Congress

October 15, 2026

WLC Partner and Co-Founder Bob Thomas was a panelist at this year’s Annual Pharmaceutical and Medical Device Ethics and Compliance Congress, one of the nation’s premier gatherings for compliance, legal, and ethics professionals in the pharmaceutical and medical device sectors.

Pharma Congress

Hosted in Washington, D.C., the 27th Annual Pharmaceutical and Medical Device Ethics and Compliance Congress brings together leading government officials, compliance executives, in-house counsel, and industry experts to discuss emerging enforcement trends, regulatory developments, and best practices in corporate compliance.

Mr. Thomas, along with fellow FCA practitioners Mary Inman and Gregg Shapiro, participated in the session titled “Whistleblower Complaints: Responding Qui Tam Complaints, Managing Internal Investigations, Whistleblower Risk & Escalation Decisions.” The program focused on some of the most pressing challenges organizations face when addressing whistleblower allegations, conducting internal investigations, evaluating escalation pathways, and responding to potential False Claims Act and qui tam exposure.

Bob Thomas

Bob Thomas brings a unique perspective to these discussions. A co-founder of Whistleblower Law Collaborative, he has spent more than two decades representing whistleblowers and helping uncover fraud through the False Claims Act and other whistleblower laws. Prior to entering private practice, he served as an Assistant United States Attorney for the District of Maryland, where he focused on white-collar fraud and environmental crime prosecutions.

His extensive experience advising whistleblowers and litigating complex qui tam matters makes him particularly well-positioned to address the evolving relationship between corporate compliance programs and whistleblower reporting. Organizations today are increasingly expected not only to investigate concerns thoroughly, but also to foster cultures that encourage transparency, accountability, and ethical decision-making before issues become significant enforcement matters.

In addition to his active legal practice, Mr. Thomas has long been recognized as a thought leader and educator in healthcare fraud and whistleblower law. He teaches courses on Health Care Fraud and Abuse and Whistleblower Law & Practice at Boston University School of Law, and regularly speaks at national conferences on compliance, False Claims Act enforcement, and whistleblower-related issues.